BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 26, 2010
View Archived Issues
Takeda reviews first half of fiscal year 2010
Read More
Reticulon-4 is a putative biomarker and inducer of pathogenesis in PAH
Read More
Tasocitinib leads to sustained improvement in patients with rheumatoid arthritis
Read More
First-in-human data presented on RO-5126766 in advanced/metastatic solid tumors
Read More
AMG-557 dose-dependently blocks ICOS ligand on B cells in patients with SLE
Read More
PA-21 is safe and reduces hyperphosphatemia in subjects with CKD on hemodialysis
Read More
AnaptysBio begins to receive QTDP grants in support of four programs
Read More
Novo Nordisk reports R&D highlights of third quarter 2010
Read More
Boehringer Ingelheim claims new chemokine CXCR3 receptor antagonists
Read More
Axikin Pharma presents new chemokine CCR3 receptor antagonists
Read More
Institute for OneWorld Health claims new CFTR inhibitors
Read More
New oxalato complexes of platinum disclosed for treatment of cancer
Read More
Banyu Pharma patents new antagonists of peptide P518 receptor
Read More
Vexon divulges new peptide derivatives with analgesic activity
Read More
Nostrum Pharma and IMTECH enter license agreement in India for new thrombolytics
Read More
Health Canada approves Allergan's Restasis for dry eye disease
Read More
FDA clears Auris Medical's IND for phase II AM-101 trial in acute inner ear tinnitus
Read More
Auris Medical advances phase IIb trial of AM-111 in acute sensorineural hearing loss
Read More
Covidian licenses drug delivery platform technology from UBC and CDRD
Read More
Clavis Pharma secures capital to advance anticancer pipeline
Read More
FDA extends review period of cladribine tablets for relapsing forms of MS
Read More
Basilea and Astellas change primary endpoint for phase III isavuconazole trial in aspergillosis
Read More
Verona confirms delivery of RPL-554 by standard asthma inhaler devices
Read More
Beech Tree Labs closes financing and receives U.S. government grant
Read More
Compugen develops new platform to discover new members of protein families
Read More